AT-Patch (ATP-C130/ATP-C70) vs Strain AI
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require extended, continuous cardiac rhythm monitoring for up to 14 days to detect intermittent arrhythmias or evaluate treatment effectiveness. Its wearable, shower-proof design and integrated AI analysis make it ideal for patients needing comfortable, long-term ambulatory ECG monitoring without frequent device interaction.
View AT-Patch (ATP-C130/ATP-C70) →Choose Strain AI if…
Choose Strain AI if you need real-time, AI-driven quantitative assessment of cardiac function directly from ultrasound images, specifically for measuring Global Longitudinal Strain (GLS). This tool is best suited for clinicians evaluating heart failure, cardiotoxicity, or other conditions requiring immediate, objective insights into myocardial mechanics during an ultrasound examination.
View Strain AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | Strain AI |
|---|---|---|
| Pricing | N/a | Contact for pricing |
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-device AI, operates without internet connection. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch prioritizes patient comfort and ease of use for long-term monitoring with its lightweight, shower-proof design and no-maintenance operation, enhancing patient compliance. The accompanying AT-Note smartphone app further streamlines the patient experience for symptom recording and live ECG viewing.
Clinical Value
Strain AIBoth tools are FDA-cleared and offer significant clinical value in cardiology. Strain AI provides objective, quantitative Global Longitudinal Strain (GLS) measurements from ultrasound images, which is a critical metric for early detection and management of conditions like heart failure and cardiotoxicity. This automation and standardization of a key diagnostic parameter can lead to more consistent and accurate assessments.
Pricing & Value
TieNeither AT-Patch nor Strain AI provides publicly available pricing information, making a direct comparison of cost-effectiveness impossible. Both offer distinct clinical benefits that could provide significant value to healthcare institutions, but without pricing transparency, a winner cannot be determined.
Enterprise Readiness
Strain AIStrain AI explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for healthcare data security. Its on-device AI deployment, operating without an internet connection and integrating with existing ultrasound devices, offers superior operational simplicity and data security for enterprise environments.
Innovation
Strain AIStrain AI's innovation lies in providing real-time, on-device AI insights for automated Global Longitudinal Strain (GLS) measurement from cardiac ultrasound images, significantly streamlining a complex diagnostic process. This capability reduces manual interpretation and improves efficiency at the point of care, representing a transformative step in diagnostic imaging.
Support & Docs
AT-Patch (ATP-C130/ATP-C70)AT-Patch offers comprehensive and easily accessible user manuals and technical documentation for both patient device usage and clinician software analysis. In contrast, while Exo (the company behind Strain AI) provides technical documentation for its underlying AI platform, specific clinical user support and documentation for Strain AI's application appear less readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | Strain AI |
|---|---|---|
| Product Name | AT-Patch (ATP-C130/ATP-C70) | Strain AI |
| Company | ATsens Co. | Exo |
| Primary Function | Wearable ECG monitor for continuous cardiac monitoring. | AI-powered medical software that analyzes cardiac ultrasound images. |
| AI Application | AI-powered analysis software for enhanced arrhythmia detection; AI/machine learning algorithms for ECG analysis. | Analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS); AI-driven solutions. |
| Key Measurement/Output | Continuous ECG monitoring; live ECG viewing; ECG analysis reports. | Global Longitudinal Strain (GLS); quantitative strain measurements. |
| Target Use Case | Continuous cardiac monitoring for arrhythmia detection. | Assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Strain AI.